Mortality from Pulmonary Embolism by Clinical Severity
sunset in florence


pulmonary embolism
submassive pulmonary embolism

How to Cite

Asthana, A., Konar, N., & Chakravorty, I. (2020). Mortality from Pulmonary Embolism by Clinical Severity . The Physician, 6(2).


Aim: To report all-cause and PE related short term mortality by clinical severity of PE and to identify any missed opportunities for thrombolysis. Background: Mortality related to pulmonary embolism varies widely in the reported literature even for the same clinical severity category of PE. Method: Electronic medical records of all patients presenting to a large tertiary care teaching hospital in London, between October 1, 2018, and January 16, 2020, who had a discharge diagnosis of acute pulmonary embolism were reviewed retrospectively. Results: There was no PE related mortality in the low-risk PE group. There was one PE related death in the submassive PE group (1.47% mortality on day 14 and day 30).  Massive PE was associated with a 29.4% PE related mortality short-term mortality.


Horlander KT, Mannino DM, Leeper KV. Pulmonary Embolism Mortality in the United States, 1979-1998: An Analysis Using Multiple-Cause Mortality Data. Arch Intern Med. 2003;163(14):1711–1717. doi:10.1001/archinte.163.14.1711

Jimenez D, et al.for the RIETE investigators. Epidemiology, patterns of care and mortality for patients with hemodynamically unstable acute symptomatic pulmonary embolism. International Journal of Cardiology. VOLUME 269, P327-333, OCTOBER 15, 2018. doi:

Lilienfeld, David E. Decreasing mortality from pulmonary embolism in the United States, 1979–1996. International Journal of Epidemiology, Volume 29, Issue 3, June 2000, Pages 465–469,

Alpert, Joseph S., et al. Mortality in Patients Treated for Pulmonary Embolism. JAMA. 1976;236(13):1477-1480. doi:10.1001/jama.1976.03270140029017

Lehnert P., et al. Acute Pulmonary Embolism in a National Danish Cohort: Increasing Incidence and Decreasing Mortality. Thromb Haemost 2018; 118(03): 539-546

DOI: 10.1160/TH17-08-0531

Goldhaber, Samuel Z., et al. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). The Lancet;

Volume 353, Issue 9162, 24 April 1999, Pages 1386-1389. Doi:

Meyer, G., et al. for the PEITHO investigators. Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism. N Engl J Med 2014; 370:1402-1411

DOI: 10.1056/NEJMoa1302097

Sharifi, M., et al. Moderate Pulmonary Embolism Treated With Thrombolysis (from the “MOPETT” Trial). The American Journal of Cardiology. VOLUME 111, ISSUE 2, P273-277, JANUARY 15, 2013. Doi:

Piazza, G., et al for the SEATTLE II investigators. A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism. J A C C : CARDI O V AS C ULAR I NT E R V E N T IONS. VOL . 8 , NO. 10 , 2 0 1 5. doi: . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c i n . 2 0 1 5 . 0 4 . 0 2 0

Kucher, N., et al. Massive Pulmonary Embolism. Circulation. 2006;113:577–582. Doi:

Morris, Micheal F., et al. CT Findings and Long-Term Mortality After Pulmonary Embolism. AJR 2012; 198:1346–1352. Doi: DOI:10.2214/AJR.11.6801

Bernal, Alejandra G., et al. Management of PE. Expert Opinion. American College of Cardiology. Jan 27, 2020.

Kucher, N. & Goldhaber, Samuel Z. Cardiac Biomarkers for Risk Stratification of Patients With Acute Pulmonary Embolism. Circulation. 2003;108:2191–2194.

Jaff, Michael R., et al. Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension. A Scientific Statement from the American Heart Association. Circulation. 2011;123:1788–1830. Doi:

Zhou, X., Ben, S., Chen, H. et al. The prognostic value of pulmonary embolism severity index in acute pulmonary embolism: a meta-analysis. Respir Res 13, 111 (2012).

Wicki J, Perneger TV, Junod AF, Bounameaux H, Perrier A. Assessing Clinical Probability of Pulmonary Embolism in the Emergency Ward: A Simple Score. Arch Intern Med. 2001;161(1):92–97. doi:10.1001/archinte.161.1.92

Venous thromboembolic diseases: diagnosis, management and thrombophilia testing. NICE guideline [NG158]Published date: 26 March 2020

Konstantinides, Savros V., et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). European Respiratory Journal 2019; DOI: 10.1183/13993003.01647-2019

Marti, C., et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis, European Heart Journal, Volume 36, Issue 10, 7 March 2015, Pages 605–614,

Daley, M. J., Murthy, M. S., & Peterson, E. J. (2015). Bleeding risk with systemic thrombolytic therapy for pulmonary embolism: scope of the problem. Therapeutic Advances in Drug Safety, 57–66.

Chatterjee S, Chakraborty A, Weinberg I, et al. Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage: A Meta-analysis. JAMA. 2014;311(23):2414–2421. doi:10.1001/jama.2014.5990

Kucher, N., et al. Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism. Circulation. 2014;129:479–486.

Kaatz S, Ahmad D, Spyropoulos AC, Schulman S, for the Subcommittee on Control of Anticoagulation. Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH. J Thromb Haemost 2015; 13: 2119–26.

Fugate JE, Rabinstein AA. Absolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke. Neurohospitalist. 2015;5(3):110-121. doi:10.1177/1941874415578532

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2020 Array